BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32475214)

  • 1. Associations Between Serum GDF15 Concentrations, Muscle Mass, and Strength Show Sex-Specific Differences in Older Hospital Patients.
    Herpich C; Franz K; Ost M; Otten L; Coleman V; Klaus S; Müller-Werdan U; Norman K
    Rejuvenation Res; 2021 Feb; 24(1):14-19. PubMed ID: 32475214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum growth differentiation factor 15 level is associated with muscle strength and lower extremity function in older patients with cardiometabolic disease.
    Oba K; Ishikawa J; Tamura Y; Fujita Y; Ito M; Iizuka A; Fujiwara Y; Kodera R; Toba A; Toyoshima K; Chiba Y; Mori S; Tanaka M; Ito H; Harada K; Araki A
    Geriatr Gerontol Int; 2020 Oct; 20(10):980-987. PubMed ID: 32886834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum GDF15 Level Is Independent of Sarcopenia in Older Asian Adults.
    Nga HT; Jang IY; Kim DA; Park SJ; Lee JY; Lee S; Kim JH; Lee E; Park JH; Lee YH; Yi HS; Kim BJ
    Gerontology; 2021; 67(5):525-531. PubMed ID: 33690236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in systemic GDF15 across the adult lifespan and their impact on maximal muscle power: the Copenhagen Sarcopenia Study.
    Alcazar J; Frandsen U; Prokhorova T; Kamper RS; Haddock B; Aagaard P; Suetta C
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1418-1427. PubMed ID: 34617415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different roles of circulating and intramuscular GDF15 as markers of skeletal muscle health.
    Chiariello A; Conte G; Rossetti L; Trofarello L; Salvioli S; Conte M
    Front Endocrinol (Lausanne); 2024; 15():1404047. PubMed ID: 38808117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Growth Differentiation Factor 15 in Parkinson Disease.
    Yao X; Wang D; Zhang L; Wang L; Zhao Z; Chen S; Wang X; Yue T; Liu Y
    Neurodegener Dis; 2017; 17(6):251-260. PubMed ID: 28787735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of GDF15 With Inflammation and Physical Function During Aging and Recovery After Acute Hospitalization: A Longitudinal Study of Older Patients and Age-Matched Controls.
    Tavenier J; Rasmussen LJH; Andersen AL; Houlind MB; Langkilde A; Andersen O; Petersen J; Nehlin JO
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):964-974. PubMed ID: 33428715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual changes in appendicular skeletal muscle mass and quality in adults over 50 y of age, assessed using bioelectrical impedance analysis.
    Kołodziej M; Ignasiak Z; Ignasiak T
    Nutrition; 2021 Oct; 90():111342. PubMed ID: 34166898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes.
    He X; Su J; Ma X; Lu W; Zhu W; Wang Y; Bao Y; Zhou J
    Cardiovasc Diabetol; 2020 Mar; 19(1):40. PubMed ID: 32222153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Growth Differentiation Factor 15 in Skeletal Muscle of Old Taurine Transporter Knockout Mouse.
    Ito T; Nakanishi Y; Yamaji N; Murakami S; Schaffer SW
    Biol Pharm Bull; 2018; 41(3):435-439. PubMed ID: 29491220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise increases circulating GDF15 in humans.
    Kleinert M; Clemmensen C; Sjøberg KA; Carl CS; Jeppesen JF; Wojtaszewski JFP; Kiens B; Richter EA
    Mol Metab; 2018 Mar; 9():187-191. PubMed ID: 29398617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differentiation factor 15 predicts advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease.
    Koo BK; Um SH; Seo DS; Joo SK; Bae JM; Park JH; Chang MS; Kim JH; Lee J; Jeong WI; Kim W
    Liver Int; 2018 Apr; 38(4):695-705. PubMed ID: 28898507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Growth Differentiation Factor 15 (GDF15) and Cardiovascular Risk in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.
    Shin MY; Kim JM; Kang YE; Kim MK; Joung KH; Lee JH; Kim KS; Kim HJ; Ku BJ; Shong M
    J Korean Med Sci; 2016 Sep; 31(9):1413-8. PubMed ID: 27510384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDF15 Plasma Level Is Inversely Associated With Level of Physical Activity and Correlates With Markers of Inflammation and Muscle Weakness.
    Conte M; Martucci M; Mosconi G; Chiariello A; Cappuccilli M; Totti V; Santoro A; Franceschi C; Salvioli S
    Front Immunol; 2020; 11():915. PubMed ID: 32477368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of circulating calciprotein particle levels with skeletal muscle mass and strength in middle-aged and older adults.
    Yoshioka M; Kosaki K; Matsui M; Okabe N; Saito C; Yamagata K; Kuro-O M; Maeda S
    Hypertens Res; 2022 May; 45(5):900-910. PubMed ID: 35241816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline - the Sydney Memory and Aging Study.
    Fuchs T; Trollor JN; Crawford J; Brown DA; Baune BT; Samaras K; Campbell L; Breit SN; Brodaty H; Sachdev P; Smith E
    Aging Cell; 2013 Oct; 12(5):882-9. PubMed ID: 23758647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Exercise Increases GDF15 and Unfolded Protein Response/Integrated Stress Response in Muscle in Type 2 Diabetes.
    Sabaratnam R; Kristensen JM; Pedersen AJT; Kruse R; Handberg A; Wojtaszewski JFP; Højlund K
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1754-1764. PubMed ID: 38242693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
    J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women.
    Visser M; Deeg DJ; Lips P; Harris TB; Bouter LM
    J Am Geriatr Soc; 2000 Apr; 48(4):381-6. PubMed ID: 10798463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam.
    Visser M; Deeg DJ; Lips P;
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5766-72. PubMed ID: 14671166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.